Qiu et al., 2015 - Google Patents
Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese populationQiu et al., 2015
View HTML- Document ID
- 12590489600817449287
- Author
- Qiu L
- He J
- Cheng L
- Zhou F
- Wang M
- Sun M
- Zhou X
- Li J
- Guo W
- Wang Y
- Yang Y
- Wang J
- Jin L
- Zhu X
- Wei Q
- Publication year
- Publication venue
- Oncotarget
External Links
Snippet
Published data on the association between PRKAA1 rs13361707 T> C polymorphism and gastric cancer (GCa) susceptibility were inconclusive. To derive a more precise estimation of the association, we conducted a large-scale GCa study of 1,124 cases and 1,194 controls to …
- 206010017758 Gastric cancer 0 title abstract description 69
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xu et al. | Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment | |
| Qiu et al. | Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese population | |
| Yang et al. | Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer | |
| Zhao et al. | Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma | |
| Zhou et al. | Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer | |
| Luo et al. | Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma | |
| Wang et al. | Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population | |
| Lin et al. | Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis | |
| Hua et al. | Association between genetic variants in the XPG gene and gastric cancer risk in a Southern Chinese population | |
| Shi et al. | A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma | |
| Xia et al. | Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility | |
| Miao et al. | Combined eight-long noncoding RNA signature: a new risk score predicting prognosis in elderly non-small cell lung cancer patients | |
| Hu et al. | Association of HMGB1 gene polymorphisms with lung cancer susceptibility and clinical aspects | |
| He et al. | Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population | |
| Li et al. | Genetic variation of lncRNA GAS5 contributes to the development of lung cancer | |
| Tao et al. | A seven‐DNA methylation signature as a novel prognostic biomarker in breast cancer | |
| Shen et al. | Association of sirtuins with clinicopathological parameters and overall survival in gastric cancer | |
| Marzec et al. | A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population | |
| Huang et al. | XPG gene polymorphisms and cancer susceptibility: Evidence from 47 studies | |
| Wang et al. | Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations | |
| Ge et al. | A BAP1 mutation-specific MicroRNA signature predicts clinical outcomes in clear cell renal cell carcinoma patients with wild-type BAP1 | |
| Lin et al. | A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma | |
| Tian et al. | MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis | |
| Chu et al. | Downregulation of ATP binding cassette subfamily a member 10 acts as a prognostic factor associated with immune infiltration in breast cancer | |
| Yuan et al. | Risk prediction for early-onset gastric carcinoma: a case-control study of polygenic gastric cancer in Han Chinese with hereditary background |